Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lory S Crocè

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Minerva Gastroenterology|October 26, 2020
Elastography: where are we now?Mauro Giuffrè, Antonio Colecchia, Lory S Crocè
World Journal of Hepatology|December 17, 2010
Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinomaCaecilia Hc Sukowati, Natalia Rosso, Lory S Crocè, et al.
NPJ Digital Medicine|April 23, 2024
Optimization of hepatological clinical guidelines interpretation by large language models: a retrieval augmented generation-based frameworkSimone Kresevic, Mauro Giuffrè, Milos Ajcevic, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
The Relevance of <i>SOCS1</i> Methylation and Epigenetic Therapy in Diverse Cell Populations of Hepatocellular CarcinomaLoraine Kay D Cabral, Peter Andrew C Reyes, Lory S Crocè, et al.
BMC Gastroenterology|October 13, 2009
Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatologyNorberto C Chavez-Tapia, Felix I Tellez-Avila, Giorgio Bedogni, et al.
Journal of Medical Virology|April 22, 2006
Hepatitis B virus genotypes, core promoter variants, and precore stop codon variants in patients infected chronically in North-Eastern ItalyGianna Dal Molin, Albino Poli, Lory S Crocè, et al.
BMC Gastroenterology|November 17, 2012
Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinomaCaecilia Hc Sukowati, Natalia Rosso, Devis Pascut, et al.
Biomed Research International|September 25, 2018
Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular CarcinomaCaecilia H C Sukowati, Riccardo Patti, Devis Pascut, et al.
Annals of Hepatology|April 22, 2026
Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with metabolic dysfunction-associated steatotic liver diseaseAllen Anthony Laraño, Silvia Palmisano, Deborah Bonazza, et al.
Minerva Gastroenterology|November 23, 2020
The role of elastography in alcoholic liver disease: fibrosis staging and confounding factors, a review of the current literatureMauro Giuffrè, Michele Campigotto, Anna Colombo, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Minerva Gastroenterology|October 26, 2020
Elastography: where are we now?Mauro Giuffrè, Antonio Colecchia, Lory S Crocè
World Journal of Hepatology|December 17, 2010
Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinomaCaecilia Hc Sukowati, Natalia Rosso, Lory S Crocè, et al.
NPJ Digital Medicine|April 23, 2024
Optimization of hepatological clinical guidelines interpretation by large language models: a retrieval augmented generation-based frameworkSimone Kresevic, Mauro Giuffrè, Milos Ajcevic, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
The Relevance of <i>SOCS1</i> Methylation and Epigenetic Therapy in Diverse Cell Populations of Hepatocellular CarcinomaLoraine Kay D Cabral, Peter Andrew C Reyes, Lory S Crocè, et al.
BMC Gastroenterology|October 13, 2009
Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatologyNorberto C Chavez-Tapia, Felix I Tellez-Avila, Giorgio Bedogni, et al.
Journal of Medical Virology|April 22, 2006
Hepatitis B virus genotypes, core promoter variants, and precore stop codon variants in patients infected chronically in North-Eastern ItalyGianna Dal Molin, Albino Poli, Lory S Crocè, et al.
BMC Gastroenterology|November 17, 2012
Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinomaCaecilia Hc Sukowati, Natalia Rosso, Devis Pascut, et al.
Biomed Research International|September 25, 2018
Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular CarcinomaCaecilia H C Sukowati, Riccardo Patti, Devis Pascut, et al.
Annals of Hepatology|April 22, 2026
Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with metabolic dysfunction-associated steatotic liver diseaseAllen Anthony Laraño, Silvia Palmisano, Deborah Bonazza, et al.
Minerva Gastroenterology|November 23, 2020
The role of elastography in alcoholic liver disease: fibrosis staging and confounding factors, a review of the current literatureMauro Giuffrè, Michele Campigotto, Anna Colombo, et al.
Pageof 2